(Q30573969)

13 August 2017

Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study (English)

1 reference

13 August 2017

1 reference

10

Nina Friis-Møller

1 reference

13 August 2017

5

Stephane De Wit

1 reference

Antonella d'Arminio Monforte

13 August 2017

9

Antonella D'Arminio Monforte

0 references

Jens Lundgren

Jens D Lundgren

11

0 references

Wafaa El-Sadr

8

Wafaa El-Sadr

1 reference

ORCID Public Data File 2021

13 August 2017

1 reference

Antonio Chiesi

1 reference

ORCID Public Data File 2021

D:A:D study group

13

D:A:D Study Group

1 reference

13 August 2017

7

Peter Reiss

1 reference

13 August 2017

6

Mathias Bruyand

1 reference

13 August 2017

1

Kathy Petoumenos

1 reference

13 August 2017

2

Signe W Worm

1 reference

13 August 2017

3

Eric Fontas

1 reference

13 August 2017

Rainer Weber

4

1 reference

13 August 2017

Matthew G Law

12

1 reference

13 August 2017

language of work or name

1 reference

10 October 2012

1 reference

Journal of the International AIDS Society

13 August 2017

1 reference

13 August 2017

15

1 reference

13 August 2017

2

1 reference

13 August 2017

17426

1 reference

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494158

HIV infection and the risk of diabetes mellitus.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494158

European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494158

Risk factors for new-onset diabetes mellitus in patients receiving protease inhibitor therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494158

Atherogenic lipid profile and cardiovascular risk factors in HIV-infected patients (Nétar Study).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494158

Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494158

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494158

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494158

The meaning and use of the area under a receiver operating characteristic (ROC) curve

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494158

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

28 July 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Cardiovascular disease risk factors and antiretroviral therapy in an HIV-positive UK population

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

21 January 2018

Abacavir and diabetes

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study.

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

21 January 2018

1 reference

https://api.crossref.org/works/10.7448%2FIAS.15.2.17426

Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23078769

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Diagnosis and classification of diabetes mellitus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23078769

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.7448/IAS.15.2.17426

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

23078769

1 reference